Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction in uraemia.

Jerry Cross1

  • 1Department of Medicine, Centre for Clinical Pharmacology and Therapeutics, London, UK. jenny.cross@clara.net

Blood Purification
|September 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Composition of Strawberry Floral Volatiles and their Effects on Behavior of Strawberry Blossom Weevil, Anthonomus rubi.

Journal of chemical ecology·2020
Same author

Identification of Novel Pesticides for Use against Glasshouse Invertebrate Pests in UK Tomatoes and Peppers.

Insects·2015
Same author

Further studies on sex pheromones of female Lygus and related bugs: development of effective lures and investigation of species-specificity.

Journal of chemical ecology·2014
Same author

(2S,8Z)-2-butyroxy-8-heptadecene: major component of the sex pheromone of chrysanthemum gall midge, Rhopalomyia longicauda.

Journal of chemical ecology·2009

Cardiovascular disease is common in chronic renal failure (CRF). Endothelial dysfunction, particularly reduced nitric oxide (NO) bioavailability, contributes to this risk and may be a therapeutic target.

Area of Science:

  • Vascular Biology
  • Nephrology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in patients with chronic renal failure (CRF).
  • The endothelium, crucial for vascular homeostasis, exhibits dysfunction in CRF, preceding overt atherosclerosis.
  • Endothelial dysfunction in CRF predicts cardiovascular morbidity and mortality.

Purpose of the Study:

  • To investigate the mechanisms of endothelial dysfunction in CRF.
  • To understand the role of nitric oxide (NO) reduction in CRF-associated CVD.
  • To identify potential therapeutic targets for preventing CVD in CRF patients.

Main Methods:

  • Review of existing literature on endothelial function in CRF.
  • Analysis of factors affecting nitric oxide (NO) bioavailability.

Related Experiment Videos

  • Exploration of mechanisms of NO synthase inhibition and NO quenching.

    • Main Results:

    • Endothelial dysfunction is a consistent finding in CRF, independent of anatomical disease.
    • Reduced nitric oxide (NO) bioavailability is a key feature of endothelial dysfunction in CRF.
    • Potential mechanisms include substrate limitation, NO synthase inhibition, and increased oxidative stress.

    Conclusions:

    • Endothelial dysfunction and reduced NO bioavailability are critical in CRF-related CVD pathogenesis.
    • Understanding these mechanisms offers potential for early therapeutic interventions.
    • Targeting endothelial dysfunction may mitigate cardiovascular risk in CRF patients.